Statin treatment, new-onset diabetes, and other adverse effects: a systematic review (Q38181977)

30 August 2017

Statin treatment, new-onset diabetes, and other adverse effects: a systematic review (English)

1 reference

30 August 2017

1 reference

language of work or name

1 reference

1 March 2014

1 reference

Current cardiology reports

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464306%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464306%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

461

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464306%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464306%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11886-013-0461-4

2 June 2020

exact match

0 references

cites work

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statin-associated memory loss: analysis of 60 case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statins and risk of polyneuropathy: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statins and risk of treated incident diabetes in a primary care population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Risk of incident diabetes among patients treated with statins: population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial--Blood Pressure Lowering Arm and the relative influence of antihypertensive medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Glucocorticoid-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Adherence to preventive statin therapy according to socioeconomic position

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Hydrophobic statins induce autophagy and cell death in human rhabdomyosarcoma cells by depleting geranylgeranyl diphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Cholesterol and cataracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statins modulate heat shock protein expression and enhance retinal ganglion cell survival after transient retinal ischemia/reperfusion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Role of statins in the development and progression of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Rational for statin use in psoriatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

Statins reduce new-onset atrial fibrillation in a first-time myocardial infarction population: a nationwide propensity score-matched study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-013-0461-4

High-dose atorvastatin after stroke or transient ischemic attack

21 January 2018

1 reference

12 December 2020

Preferable effect of pravastatin compared to atorvastatin on beta cell function in Japanese early-state type 2 diabetes with hypercholesterolemia

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk

1 reference

12 December 2020